Johnson & Johnson Pharmaceutical Recall

Johnson & Johnson has recalled nearly five million packages of the popular over-the-counter medications Benadryl and Motrin because a J&J review “revealed insufficiencies in the development of the manufacturing process,” J&J said. The recall applied to four million packages of Children’s Benadryl Allergy Fastmelt Tablets in cherry and grape flavors, distributed in the U.S. and elsewhere, as well as 800,000 bottles of the painkiller Junior Strength Motrin Caplets, which had been distributed in the U.S.

The company also recalled about 71,000 packages of Rolaid antacid from throughout the United States. The Rolaids, according to J&J, had been produced by a third party, and were recalled due to consumer complaints regarding “an uncharacteristic consistency or texture, traced to crystallized sugar in the product.”
The recall, like earlier recalls of Tylenol and other consumer items during the past year, involved products at the company’s Fort Washington, Pennsylvania, facility. That facility was shut earlier in the year to deal with quality-control issues, including unsanitary conditions.

Johnson & Johnson stated that the recall was for wholesale and retail outlets; “consumers do not have to take any action,” their spokeswoman said.